Attached files

file filename
EX-31.1 - EX-31.1 - UNITED THERAPEUTICS Corpa2234069zex-31_1.htm
EX-32.2 - EX-32.2 - UNITED THERAPEUTICS Corpa2234069zex-32_2.htm
10-K - 10-K - UNITED THERAPEUTICS Corpa2234069z10-k.htm
EX-32.1 - EX-32.1 - UNITED THERAPEUTICS Corpa2234069zex-32_1.htm
EX-31.2 - EX-31.2 - UNITED THERAPEUTICS Corpa2234069zex-31_2.htm
EX-21 - EX-21 - UNITED THERAPEUTICS Corpa2234069zex-21.htm
EX-10.52 - EX-10.52 - UNITED THERAPEUTICS Corpa2234069zex-10_52.htm
EX-10.51 - EX-10.51 - UNITED THERAPEUTICS Corpa2234069zex-10_51.htm
EX-10.45 - EX-10.45 - UNITED THERAPEUTICS Corpa2234069zex-10_45.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following Registration Statements:

 

(1)

Registration Statement (Form S-8 No. 333-108169) pertaining to Employee Options and Consultant Options Granted Outside the United Therapeutics Corporation’s Equity Incentive Plan,

 

 

(2)

Registration Statement (Form S-8 No. 333-56922) pertaining to Employee Options and Consultant Options Granted Outside the United Therapeutics Corporation’s Equity Incentive Plan,

 

 

(3)

Registration Statement (Form S-8 No. 333-95419) pertaining to the United Therapeutics Corporation’s Equity Incentive Plan,

 

 

(4)

Registration Statement (Form S-8 No. 333-153695) pertaining to the United Therapeutics Corporation Share Tracking Awards Plan,

 

 

(5)

Registration Statement (Form S-8 No. 333-173858) pertaining to the United Therapeutics Corporation 2011 Share Tracking Awards Plan,

 

 

(6)

Registration Statement (Form S-4 No. 333-173857) pertaining United Therapeutics Corporation common stock,

 

 

(7)

Registration Statement (Form S-8 No. 333-179746) pertaining to the United Therapeutics Corporation 2011 Share Tracking Awards Plan,

 

 

(8)

Registration Statement (Form S-8 No. 333-182851) pertaining to the United Therapeutics Corporation Employee Stock Purchase Plan,

 

 

(9)

Registration Statement (Form S-8 No. 333-188241) pertaining to the United Therapeutics Corporation 2011 Share Tracking Awards Plan,

 

 

(10)

Registration Statement (Form S-8 No. 333-197685) pertaining to the United Therapeutics Corporation 2011 Share Tracking Awards Plan, and

 

 

(11)

Registration Statement (Form S-8 No. 333-205309) pertaining to the United Therapeutics Corporation 2015 Stock Incentive Plan.

 

of our reports dated February 21, 2018, with respect to the consolidated financial statements and schedule of United Therapeutics Corporation and the effectiveness of United Therapeutics Corporation’s internal control over financial reporting, included in this Annual Report (Form 10-K) for the year ended December 31, 2017.

 

/s/ Ernst & Young LLP

 

 

 

Tysons, Virginia

February 21, 2018